Abstract
Although risks are present, intravitreal corticosteroid injection is a relatively safe and effective treatment in a variety of conditions. Risks of intravitreal steroid injection include, but are not limited to, elevation of intraocular pressure, infection, cataract, retinal detachment, and central retinal artery occlusion. Although most observations regarding intravitreal corticosteroid injection derive from treating diabetic macular edema and age-related macular degeneration, this approach is beneficial in a number of uveitic conditions.
Original language | English (US) |
---|---|
Title of host publication | Surgical Management of Inflammatory Eye Disease |
Publisher | Springer Berlin Heidelberg |
Pages | 5-16 |
Number of pages | 12 |
ISBN (Print) | 9783540338611 |
DOIs | |
State | Published - 2008 |
ASJC Scopus subject areas
- Medicine(all)